These compounds may interact with:
Sodium- and chloride-dependent glycine transporter 2
Potentially involved in: hyperekplexia; melanoma; kidney cancer; carcinoma; skin cancer; glycine encephalopathy; schizophrenia; dystonia; alcoholic intoxication, chronic; apnea; brain diseases; muscle hypertonia; muscular stiffness; hyperexplexia; exaggerated startle response; hereditary hyperexplexia; exaggerated acoustic startle response; increased startle response; infantile onset; hyperekplexia 3
Disease data sourced from Pharos.